Ascendis Pharma A/S (ASND) — 6-K Filings

6-K Filings (43)

• 6-K Filing — Apr 20, 2026
• 6-K Filing — Apr 8, 2026
• 6-K Filing — Apr 8, 2026
• 6-K Filing — Apr 7, 2026
• Ascendis Pharma Files Routine 6-K; No New Material Info — Mar 24, 2026
  Ascendis Pharma A/S filed a 6-K on March 24, 2026, which is a routine report for foreign issuers. This specific filing, with accession number 0001193125-26-1217
• Ascendis Pharma Files December 2025 6-K Report — Dec 30, 2025 Risk: low
  Ascendis Pharma A/S, a pharmaceutical company, filed a Form 6-K on December 30, 2025. This report is for the month of December 2025 and is being filed under the
• 6-K Filing — Dec 10, 2025
• Ascendis Pharma Files 6-K Report — Nov 26, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on November 26, 2025, for the month of November 2025. The company, incorporated in G7 with its principal executive offices
• 6-K Filing — Nov 12, 2025
• Ascendis Pharma Files 6-K for S-8 Registration — Oct 22, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on October 22, 2025, to report information as a foreign private issuer. The filing is related to their registration stateme
• Ascendis Pharma Files October 2025 6-K Report — Oct 15, 2025 Risk: low
  Ascendis Pharma A/S, a biopharmaceutical company, filed a Form 6-K on October 15, 2025. This report is for the month of October 2025 and is filed under the Secu
• Ascendis Pharma Files 6-K for S-8 Registration — Oct 8, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on October 8, 2025, to report information as a foreign private issuer. The filing is related to their registration statemen
• Ascendis Pharma Files 6-K for September 2025 — Sep 30, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on September 30, 2025, to report information as a foreign private issuer. The filing indicates that the company will file a
• Ascendis Pharma Files 6-K, Incorporates by Reference — Sep 10, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on September 10, 2025, to report information as a foreign private issuer. The filing is related to registration statements
• Ascendis Pharma Files 6-K, Incorporates by Reference — Aug 13, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on August 13, 2025, to report information as a foreign private issuer. The filing is related to registration statements on
• Ascendis Pharma Reports Q2 2025 Financial Results — Aug 7, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on August 7, 2025, to report its financial results for the fiscal quarter ended June 30, 2025. The filing includes a press
• Ascendis Pharma Files 6-K for June 30, 2025 — Aug 7, 2025 Risk: low
  Ascendis Pharma A/S filed a 6-K report as of June 30, 2025. The filing includes financial data and details related to its operations, such as issued capital and
• Ascendis Pharma Files 6-K for S-8 Registration — Jul 28, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on July 28, 2025, to report information as a foreign private issuer. The filing is related to their registration statements
• Ascendis Pharma Files 6-K, Incorporates by Reference — Jul 9, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on July 9, 2025, to report information as a foreign private issuer. The filing is related to registration statements on For
• Ascendis Pharma Files 6-K for S-8 Registration Updates — Jun 27, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on June 27, 2025, to incorporate by reference into its existing Form S-8 registration statements. These S-8 filings are rel
• Ascendis Pharma Files 6-K for June 2025 — Jun 11, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on June 11, 2025, to report information as a foreign private issuer. The filing is incorporated by reference into several S
• Ascendis Pharma Files 6-K, Incorporates into S-8 Filings — Jun 9, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on June 9, 2025, to report information as a foreign private issuer. This filing is incorporated by reference into several o
• Ascendis Pharma Files 6-K for S-8 Registration — Jun 2, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on June 2, 2025, to incorporate by reference into its existing S-8 registration statements. These statements relate to the
• Ascendis Pharma Files 6-K for S-8 Registration — May 28, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on May 28, 2025, to incorporate by reference into its existing Form S-8 registration statements. These statements are used
• Ascendis Pharma Files 6-K Report — May 14, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on May 14, 2025, to report its activities as a foreign private issuer. The filing indicates that the company is subject to
• Ascendis Pharma A/S Reports Q1 2025 Financial Results — May 1, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on May 1, 2025, to report its financial results for the fiscal quarter ended March 31, 2025. The filing includes a press re
• Ascendis Pharma Files 6-K with Q1 2025 Financials — May 1, 2025 Risk: low
  Ascendis Pharma A/S filed a 6-K report on May 1, 2025, for the period ending March 31, 2025. The filing includes financial information such as share premium and
• Ascendis Pharma A/S Announces Annual General Meeting Notice — Apr 29, 2025 Risk: low
  Ascendis Pharma A/S has filed a Form 6-K on April 29, 2025, to provide a convening notice for its Annual General Meeting. This notice informs the company's shar
• Ascendis Pharma Files Routine 6-K Disclosure — Apr 9, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on April 9, 2025, to report information as a foreign private issuer. The filing does not contain specific financial figures
• Ascendis Pharma Files March 2025 6-K Report — Mar 31, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on March 31, 2025, for the month of March 2025. This report is a routine filing for foreign private issuers and does not co
• Ascendis Pharma Files 6-K for SEC Reporting — Mar 28, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on March 28, 2025, to report information as a foreign private issuer. The filing is incorporated by reference into several
• Ascendis Pharma Files Routine 6-K Disclosure — Mar 20, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on March 20, 2025, to report its activities as a foreign private issuer. The filing does not contain specific financial fig
• Ascendis Pharma Files 6-K, Incorporates into S-8 Filings — Mar 12, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on March 12, 2025, to report information as a foreign private issuer. The filing is incorporated by reference into several
• Ascendis Pharma Files 6-K Report — Feb 12, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on February 12, 2025, to report information as a foreign private issuer. The filing indicates that the company is subject t
• Ascendis Pharma Files 6-K Report — Jan 15, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on January 15, 2025, to report its activities for the month of January 2025. The filing is a report of a foreign private is
• Ascendis Pharma Files Routine 6-K — Jan 13, 2025 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on January 13, 2025, to report information as a foreign private issuer. The filing does not contain specific financial figu
• Ascendis Pharma Files 6-K for December 2024 — Dec 30, 2024 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on December 30, 2024, to report information as a foreign private issuer. The filing is for the month of December 2024 and i
• Ascendis Pharma Files 6-K for December 2024 — Dec 17, 2024 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on December 17, 2024, to report information as a foreign private issuer. The filing is for the month of December 2024 and i
• Ascendis Pharma Files 6-K Report — Dec 12, 2024 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on December 12, 2024, to report its activities for the month of December 2024. The filing is a routine report for foreign p
• Ascendis Pharma Files 6-K with SEC — Dec 11, 2024 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on December 11, 2024, to report information as a foreign private issuer. The filing indicates that the company will file an
• Ascendis Pharma Reports Q3 2024 Financial Results — Nov 14, 2024 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on November 14, 2024, to report its financial results for the fiscal quarter ended September 30, 2024. The filing includes
• Ascendis Pharma Files 6-K with Q3 2024 Financials — Nov 14, 2024 Risk: low
  Ascendis Pharma A/S filed a 6-K report on November 14, 2024, detailing financial information as of September 30, 2024. The filing includes data on financial ass
• Ascendis Pharma Files 6-K Report — Nov 13, 2024 Risk: low
  Ascendis Pharma A/S filed a Form 6-K on November 13, 2024. This report is for the month of November 2024 and is filed by a foreign private issuer. The company i

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX